CLAIM #48613 · Pfizer Inc (PFE) · 2025Q2 earnings call · Aug 5, 2025 · due Feb 5, 2026
“In the short term, Padcev and the readouts for the muscle invasive bladder cancer studies... we expect those readouts in the next 6 months.”
Chris Boshoff · Executive
CANNOT_DETERMINE
versus commitment · official band 5 percent
Committed
we expect those readouts in the next 6 months
Reported
During the quarter, we presented notable EV-304 study findings for Padcev at ASCO GU
Verify independently
SEC filings for PFE ↗ · Claim quote is verbatim from the 2025Q2 earnings call.